BUZZ-Australia's Cyclopharm soars on diagnostic tech deployment contract

** Shares of Cyclopharm CYC.AX up 17.2% at A$2.38

** Stock rises as much as 23.2% to A$2.5 in early trade, hitting its highest level since Oct 16, 2023

** Radiopharmaceutical firm signs contract with healthcare provider Hospital Corporation of America Healthcare (HCA)

** Says contract for deployment of co's Technegas imaging technology in up to 169 nuclear medicine departments across HCA'S network

** Co did not provide any transactional details regarding contract

** Technegas imaging technology is used to detect pulmonary embolism

** More than 502,000 shares change hands, 5.8 times the 30-day avg

** Cyclopahrm up 49.5% YTD, including current session's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))